Giulio C. Spagnoli mainly focuses on Immunology, Molecular biology, Antigen, Cytotoxic T cell and Pathology. His studies in Molecular biology integrate themes in fields like Gene product, Gene expression, Cell growth, Antigen-presenting cell and Melanoma. His Antigen research is multidisciplinary, incorporating elements of Immunotherapy, Cancer immunotherapy and Antigen presentation.
His research integrates issues of Cell culture and T cell, Dendritic cell, Immune system in his study of Cytotoxic T cell. His research in Pathology intersects with topics in Epitope, Colorectal cancer and CD8. His CD8 research focuses on Cancer research and how it relates to Arginase.
Giulio C. Spagnoli focuses on Antigen, Immunology, Cytotoxic T cell, Pathology and Cancer research. His biological study deals with issues like Monoclonal antibody, which deal with fields such as T-cell receptor. His Immunology research includes elements of Peripheral blood mononuclear cell and Melanoma.
He has researched Cytotoxic T cell in several fields, including Molecular biology, Cell culture, CD8 and T cell. His biological study spans a wide range of topics, including Cancer, Cancer/testis antigens and In vivo. His Cancer research study incorporates themes from Cancer cell, Cell, Colorectal cancer and Mesenchymal stem cell.
His scientific interests lie mostly in Cancer research, Colorectal cancer, Pathology, Cancer and Immunology. His Cancer research research incorporates elements of Cancer cell, Cell, Apoptosis and In vivo. His studies deal with areas such as Mesenchymal stem cell, CD8, Immune system and Oncology as well as Colorectal cancer.
His Pathology research is multidisciplinary, relying on both Tumor progression, Perfusion bioreactor, Biomedical engineering and Primary breast cancer. Many of his studies on Immunology apply to Cytotoxic T cell as well. He interconnects CXCL10 and Cell culture in the investigation of issues within Cytotoxic T cell.
His main research concerns Cancer research, Pathology, Cancer, Immunology and Cytotoxic T cell. His Cancer research study combines topics from a wide range of disciplines, such as Cell, Cancer cell, Transcriptome, Downregulation and upregulation and In vivo. His research in Pathology intersects with topics in Head and neck squamous-cell carcinoma, Head and neck cancer, Colorectal cancer and NY-ESO-1.
His Cancer/testis antigens and Tumor microenvironment study, which is part of a larger body of work in Cancer, is frequently linked to Indoleamine 2,3-dioxygenase, bridging the gap between disciplines. Immunology and Cell biology are commonly linked in his work. His study looks at the relationship between Cytotoxic T cell and fields such as T cell, as well as how they intersect with chemical problems.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells.
Andreas Mackensen;Birgit Herbst;Ji-Li Chen;Gabriele Köhler.
International Journal of Cancer (2000)
Clinical impact of programmed cell death ligand 1 expression in colorectal cancer.
Raoul A. Droeser;Raoul A. Droeser;Christian Hirt;Christian Hirt;Carsten T. Viehl;Daniel M. Frey.
European Journal of Cancer (2013)
Quantitative analysis of gene expression in human articular cartilage from normal and osteoarthritic joints
I. Martin;M. Jakob;D. Schäfer;W. Dick.
Osteoarthritis and Cartilage (2001)
Three‐dimensional culture of melanoma cells profoundly affects gene expression profile: A high density oligonucleotide array study
Sourabh Ghosh;Giulio C. Spagnoli;Ivan Martin;Sabine Ploegert.
Journal of Cellular Physiology (2005)
Melanoma Cells Present a MAGE-3 Epitope to CD4+ Cytotoxic T Cells in Association with Histocompatibility Leukocyte Antigen DR11
Simona Manici;Tiziana Sturniolo;Maria Adele Imro;Juergen Hammer.
Journal of Experimental Medicine (1999)
Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer
A Lugli;G Iezzi;I Hostettler;M G Muraro.
British Journal of Cancer (2010)
Involvement of the multilineage CD38 molecule in a unique pathway of cell activation and proliferation.
A Funaro;G C Spagnoli;C M Ausiello;M Alessio.
Journal of Immunology (1990)
IFN-α2a induces IP-10/CXCL10 and MIG/CXCL9 production in monocyte-derived dendritic cells and enhances their capacity to attract and stimulate CD8+ effector T cells
Elisabetta Padovan;Giulio C. Spagnoli;Maria Ferrantini;Michael Heberer.
Journal of Leukocyte Biology (2002)
Modulation of T-Cell Activation by Malignant Melanoma Initiating Cells
Tobias Schatton;Ute Schütte;Natasha Y. Frank;Qian Zhan.
Cancer Research (2010)
Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro
Ciara Bocelli-Tyndall;L. Bracci;G. Spagnoli;A. Braccini.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: